✦ LIBER ✦

Orphan Drugs for Rare Diseases: Grounds for Special Status

✍ Scribed by Eline Picavet; Marc Dooms; David Cassiman; Steven Simoens

Book ID: 112072834
Publisher: John Wiley and Sons
Year: 2012
Tongue: English
Weight: 76 KB
Volume: 73
Category: Article
ISSN: 0272-4391
DOI: 10.1002/ddr.21005

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Orphan drugs for tropical diseases

📂 Article 📅 1985 🏛 Elsevier Science 🌐 English ⚖ 126 KB

Drug development for “orphan” diseases

✍ Anthony Cerami 📂 Article 📅 1978 🏛 Elsevier Science 🌐 English ⚖ 190 KB

Drug repositioning for orphan diseases

✍ Sardana, D.; Zhu, C.; Zhang, M.; Gudivada, R. C.; Yang, L.; Jegga, A. G. 📂 Article 📅 2011 🏛 Oxford University Press 🌐 English ⚖ 131 KB

PHP39 PUBLIC FUNDING OF DRUGS FOR ORPHAN

PHP39 PUBLIC FUNDING OF DRUGS FOR ORPHAN DISEASES

✍ D Hughes 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 76 KB

Pivotal studies of orphan drugs approved

Pivotal studies of orphan drugs approved for neurological diseases

✍ Jun Mitsumoto; E. Ray Dorsey; Christopher A. Beck; Karl Kieburtz; Robert C. Grig 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 100 KB 👁 1 views

PHP28 Drugs for Rare Diseases: Influence

PHP28 Drugs for Rare Diseases: Influence of Oprhan Designation Status on Price

✍ E. Picavet; M. Dooms; D. Cassiman; S. Simoens 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 58 KB